Nifty Pharma Today: Index Falls as Leaders Diverge
- August 17, 2026
- Posted by: Kunal Singla
- Category: Market
Nifty Pharma today closed on a mildly negative note, reflecting a session where strong gains in a few counters were offset by declines in several large and closely tracked pharmaceutical stocks. The index stood at 26,341.55, down 104 points or 0.39% from the previous close of 26,445.55. The move was not a sharp collapse, but it did show that sellers had a slight edge by the end of the day.
The trading pattern was useful for anyone tracking sector rotation inside the Indian stock market. Nifty Pharma opened at 26,528.00, touched an intraday high of 26,537.35, and then slipped to a low of 26,312.35 before settling near the lower part of the day’s range. That intraday path suggests the sector started firm but gradually lost strength as the session progressed.
For users searching terms like Nifty Pharma live, Nifty Pharma performance, Nifty Pharma analysis, Nifty Pharma gainers, and Nifty Pharma losers, the key takeaway is simple: this was a split market inside the pharma basket. There were clear winners such as Ipca Laboratories and gainers like Torrent Pharmaceuticals and Laurus Labs, but notable drags from Sun Pharmaceutical Industries, JB Chemicals & Pharmaceuticals, Gland Pharma, and Mankind Pharma kept the overall sector in the red.
This article breaks down the complete Nifty Pharma movement using only the verified market data available for the day. It covers the index snapshot, market breadth, all tracked constituent moves, the strongest gainers, the key laggards, heavyweight behaviour, and what the day’s price action may indicate for short-term traders and long-term market observers.
Nifty Pharma Today: Sector Index Snapshot
| Metric | Value |
|---|---|
| Current Value | 26,341.55 |
| Absolute Change | -104.00 |
| Percentage Change | -0.39% |
| Opening Value | 26,528.00 |
| Previous Close | 26,445.55 |
| Day High | 26,537.35 |
| Day Low | 26,312.35 |
| Market Status | Closed |
| Last Updated | 17 August 2026 at 4:00:00 PM IST |
| Market Trend | Bearish |
The headline trend for Nifty Pharma today was mildly bearish. The sector opened above the previous close, which initially suggested positive intent. However, the index could not hold those gains. After hitting the day’s high very early in the session range, it moved lower and spent much of the day weakening toward the close.
In plain language, pharma stocks did not fall together, but the declines in important names outweighed the gains elsewhere. This type of session usually tells market participants that stock selection mattered more than the sector headline alone. A trader looking only at the index would see a modest decline, but a deeper look reveals a much more mixed internal picture.
How Nifty Pharma Moved Through the Session
The opening at 26,528.00 versus the previous close of 26,445.55 showed an early positive gap. The intraday high of 26,537.35 was only slightly above the opening level, which means the sector did not build significant upside momentum after the start. Once the early strength faded, the index drifted lower and tested 26,312.35 on the downside.
The close at 26,341.55, closer to the day’s low than the day’s high, indicates that selling pressure remained present into the latter half of trading. While the percentage decline of 0.39% is moderate, the shape of the session is important because it reflects fading intraday conviction rather than a last-minute recovery.
From a market behaviour standpoint, that pattern often suggests caution. Buyers were active in selected names, but they were not strong enough across the full pharma pack to keep the sector in positive territory.
Why Nifty Pharma Moved Lower Today
Based on the verified price and breadth data, the most relevant reason for the index decline was the combination of weakness in several notable pharma stocks and negative movement in key heavyweight names. This was not a broad washout across every stock. Instead, it was a balancing act where sharp gains in a few names were offset by losses in multiple others, especially among widely followed large companies.
Sun Pharmaceutical Industries Ltd. fell 2.49%, making it one of the most important visible drags on the sector because it also appears among the heavyweight stocks. Cipla Ltd. declined 1.28%, while Dr. Reddy’s Laboratories Ltd. slipped 0.67%. Mankind Pharma Ltd. also dropped 1.83%. When several heavyweight or high-attention stocks trade lower together, the sector index usually struggles even if smaller or mid-basket names advance.
On the positive side, Ipca Laboratories Ltd. surged 8.67%, easily becoming the standout performer of the day. Torrent Pharmaceuticals Ltd. rose 1.39%, Laurus Labs Ltd. gained 1.25%, and Ajanta Pharma Ltd. added 1.24%. These gains were meaningful, but they did not spread widely enough across the whole pack to turn the index green.
So the simplest explanation for why Nifty Pharma fell today is this: the breadth was perfectly split, but the pressure in some influential names was stronger than the uplift from the gainers. That is a classic example of a mixed sector ending with a negative headline print.
Market Breadth: What the Internal Data Says
| Market Breadth Metric | Value |
|---|---|
| Advancing Stocks | 10 |
| Declining Stocks | 10 |
| Unchanged Stocks | 0 |
| Advance-Decline Ratio | 1.00 |
| Stocks in Green | 50% |
| Stocks in Red | 50% |
Market breadth in Nifty Pharma today was exactly balanced. Ten stocks advanced and ten declined, with no stock unchanged. The advance-decline ratio of 1.00 and the equal 50% green, 50% red split confirm that this was not a broad-based bearish session.
That matters because index movement alone can sometimes hide internal strength. Here, the breadth tells us that the sector was evenly divided. In other words, half of the pharma names still managed to rise despite the index closing lower.
The interpretation is important for investors. Balanced breadth with a negative index often points to pressure concentrated in specific influential stocks rather than uniform weakness across the sector. This means sentiment was selective, not universally negative.
Complete Nifty Pharma Constituent Performance
| Company | CMP | Today’s % | Today’s Change | Day High | Day Low | Trend |
|---|---|---|---|---|---|---|
| Ipca Laboratories Ltd. | 1,884.60 | 8.67% | 150.40 | 1,945.10 | 1,805.90 | Strong Positive |
| JB Chemicals & Pharmaceuticals Ltd. | 2,408.90 | -3.87% | -97.10 | 2,525.50 | 2,380.00 | Negative |
| Sun Pharmaceutical Industries Ltd. | 1,882.00 | -2.49% | -48.00 | 1,949.80 | 1,880.40 | Negative |
| Gland Pharma Ltd. | 2,910.20 | -2.02% | -60.00 | 2,993.30 | 2,859.70 | Negative |
| Mankind Pharma Ltd. | 2,380.90 | -1.83% | -44.30 | 2,423.00 | 2,369.50 | Negative |
| Natco Pharma Ltd. | 889.80 | -1.48% | -13.35 | 897.10 | 870.20 | Negative |
| Torrent Pharmaceuticals Ltd. | 4,900.00 | 1.39% | 67.00 | 4,939.00 | 4,814.00 | Positive |
| Cipla Ltd. | 1,431.50 | -1.28% | -18.50 | 1,449.00 | 1,423.70 | Negative |
| Laurus Labs Ltd. | 1,809.70 | 1.25% | 22.40 | 1,824.00 | 1,769.40 | Positive |
| Ajanta Pharma Ltd. | 3,718.20 | 1.24% | 45.40 | 3,738.00 | 3,650.00 | Positive |
| Biocon Ltd. | 412.00 | -1.20% | -5.00 | 416.65 | 408.65 | Negative |
| Lupin Ltd. | 2,259.00 | 1.07% | 24.00 | 2,266.00 | 2,220.30 | Positive |
| Dr. Reddy’s Laboratories Ltd. | 1,192.00 | -0.67% | -8.00 | 1,204.40 | 1,178.20 | Negative |
| Abbott India Ltd. | 26,905.00 | -0.57% | -155.00 | 27,150.00 | 26,650.00 | Negative |
| Glenmark Pharmaceuticals Ltd. | 2,329.00 | 0.46% | 10.60 | 2,337.00 | 2,300.00 | Positive |
| Granules India Ltd. | 861.55 | 0.37% | 3.15 | 869.85 | 838.05 | Positive |
| Zydus Lifesciences Ltd. | 1,131.50 | -0.33% | -3.70 | 1,154.50 | 1,127.10 | Mild Negative |
| Aurobindo Pharma Ltd. | 1,627.20 | 0.31% | 5.10 | 1,652.00 | 1,617.90 | Positive |
| Alkem Laboratories Ltd. | 5,374.00 | 0.11% | 6.00 | 5,483.00 | 5,312.00 | Flat Positive |
| Divi’s Laboratories Ltd. | 8,481.50 | 0.05% | 4.50 | 8,550.00 | 8,463.50 | Flat Positive |
The top performer was clearly Ipca Laboratories Ltd., which rallied 8.67%. The worst performer was JB Chemicals & Pharmaceuticals Ltd., down 3.87%.
What stands out from the full table is the divergence between returns. The best gainer rose far more sharply than most peers, while the rest of the positive pack advanced in a narrower range. On the downside, multiple stocks fell between about 1% and 2.5%, which collectively kept the sector under pressure.
Top Gainers in Nifty Pharma Today
| Company | Price Change | % Change | Session View |
|---|---|---|---|
| Ipca Laboratories Ltd. | 150.40 | 8.67% | Strong upside leadership |
| Torrent Pharmaceuticals Ltd. | 67.00 | 1.39% | Supportive gain |
| Laurus Labs Ltd. | 22.40 | 1.25% | Steady strength |
| Ajanta Pharma Ltd. | 45.40 | 1.24% | Positive participation |
| Lupin Ltd. | 24.00 | 1.07% | Healthy advance |
The gainers list shows that Nifty Pharma did have strong pockets of buying. Ipca Laboratories was the standout mover by a wide margin, and its jump was large enough to distinguish it from the rest of the sector. Torrent Pharmaceuticals, Laurus Labs, Ajanta Pharma, and Lupin added support, but their gains were still much smaller than Ipca’s surge.
That uneven positive participation explains why the sector could not convert isolated strength into an index gain. A sector usually needs either widespread advances or strong upside moves in its biggest names. Today, the gains were real, but not broad enough or concentrated enough in the right places to change the index direction.
Top Losers in Nifty Pharma Today
| Company | Price Change | % Change | Session View |
|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. | -97.10 | -3.87% | Sharp decline |
| Sun Pharmaceutical Industries Ltd. | -48.00 | -2.49% | Key drag |
| Gland Pharma Ltd. | -60.00 | -2.02% | Notable weakness |
| Mankind Pharma Ltd. | -44.30 | -1.83% | Broad pressure |
| Natco Pharma Ltd. | -13.35 | -1.48% | Continued softness |
The draggers list is more revealing for index direction. The decline in Sun Pharmaceutical Industries Ltd. is especially important because it appears among the sector heavyweights. When one of the sector’s most watched large stocks loses nearly 2.5%, the index often feels the impact more directly.
JB Chemicals & Pharmaceuticals posted the steepest percentage decline at 3.87%, while Gland Pharma and Mankind Pharma also fell sharply. Together, these declines created enough pressure to neutralize several modest winners elsewhere in the basket.
Heavyweight Stocks: The Real Influence on the Index
Among the heavyweight stocks provided for Nifty Pharma, the day’s pattern was mixed but tilted negative. Sun Pharmaceutical Industries Ltd. declined 2.49%, Cipla Ltd. dropped 1.28%, Dr. Reddy’s Laboratories Ltd. slipped 0.67%, Mankind Pharma Ltd. lost 1.83%, and Abbott India Ltd. eased 0.57%.
On the supportive side, Divi’s Laboratories Ltd. was nearly flat but positive at 0.05%, Torrent Pharmaceuticals Ltd. rose 1.39%, Lupin Ltd. gained 1.07%, and Aurobindo Pharma Ltd. added 0.31%.
This mix shows exactly why the index finished lower despite balanced breadth. The negative prints in several key large names outweighed the more modest gains in other heavyweights. For anyone tracking Nifty Pharma live, this is often more useful than just counting gainers and losers.
Most Active Names Traders Watched
The list of most active stocks overlaps strongly with the heavyweight list, which tells us that market attention stayed concentrated in familiar leaders. The names included Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, Zydus Lifesciences, Lupin, Abbott India, and Aurobindo Pharma.
That concentration of activity matters because active names often define the tone of the sector. Today, several of these tracked names were negative, especially Sun Pharma, Cipla, Dr. Reddy’s, Mankind Pharma, and Abbott India. Even though a few active stocks gained, the more visible selling among major pharma counters left the sector under pressure.
Short-Term Technical Reading Based on Price Structure
The available data supports a practical, price-action-based technical reading. Nifty Pharma opened above the previous close, made only a marginal extension to the upside, and then slipped lower for most of the session. That intraday structure points to early strength meeting supply.
The close near the lower end of the day’s range gives the session a weak tone. In very simple terms, the market attempted to move up but was not able to attract enough follow-through buying. Sellers gradually regained control and prevented a recovery back toward the opening zone.
Because no verified moving average, RSI, MACD, VWAP, or formal support-resistance levels are provided here, the cleanest interpretation is this: near-term momentum for the day was bearish, but not aggressively so. The index did not collapse; instead, it faded after a positive open. Traders will often read such a move as a sign that the sector needs stronger broad participation before it can resume upside momentum.
A useful visual reference from the session itself is the intraday range. The high was 26,537.35 and the low was 26,312.35. The close at 26,341.55 was much closer to the low than the high, which reinforces the weak end-of-day setup.
Historical Performance View Using Available Timeframe
| Period | Level / Change |
|---|---|
| Today | 26,341.55 (-0.39%) |
| Previous Session Close | 26,445.55 |
| Intraday Open | 26,528.00 |
| Intraday High | 26,537.35 |
| Intraday Low | 26,312.35 |
Using the available verified timeframe, Nifty Pharma’s immediate historical comparison is straightforward. The index moved from 26,445.55 in the previous session to 26,341.55 today, a decline of 104 points. While that is not a major one-day loss, it does place the sector on the back foot for the latest session.
The intraday comparison is equally informative. An open above the previous close followed by a close below the open shows a reversal of early positive tone. That kind of shift is important for short-term traders who track whether sectors sustain opening momentum or give it up through the day.
What Investors Should Watch Next in Nifty Pharma
Based on today’s data, investors and traders should watch whether the split inside the sector resolves in favor of the gainers or the laggards. A balanced breadth day can often lead to a stronger directional move in the following session if either buyers or sellers gain control across more names.
The first thing to monitor is whether heavyweight stocks stabilize. If stocks such as Sun Pharmaceutical Industries, Cipla, Dr. Reddy’s Laboratories, and Mankind Pharma remain weak, the index may continue to struggle even if select mid-pack stocks outperform.
The second thing to watch is whether standout gainers can build follow-through. Ipca Laboratories was the clearest bullish pocket inside the index today. If names like Ipca, Torrent Pharmaceuticals, Laurus Labs, Ajanta Pharma, and Lupin continue to attract buying, they can improve internal sentiment even if the full sector does not turn immediately.
Finally, traders should keep an eye on the index’s own behavior relative to today’s range. A move back above the opening and high zone would suggest improving momentum, while continued trading near or below the lower end of the range would indicate that the day’s bearish tone is carrying forward.
Key Takeaways from Nifty Pharma Today
- Nifty Pharma closed at 26,341.55, down 104 points or 0.39%.
- The index opened strong but faded during the session and closed near the day’s low.
- Market breadth was perfectly balanced with 10 advancers and 10 decliners.
- Ipca Laboratories Ltd. was the top performer, rising 8.67%.
- JB Chemicals & Pharmaceuticals Ltd. was the top loser, down 3.87%.
- Weakness in heavyweight names, especially Sun Pharmaceutical Industries Ltd., was a major reason the index stayed negative.
- The session reflected selective stock-specific buying rather than broad sector strength.
Featured Snippet Ready Answers
What is Nifty Pharma?
Nifty Pharma is a sectoral stock market index that tracks listed pharmaceutical companies on the NSE. It helps investors monitor the overall performance, breadth, and direction of major pharma stocks in India.
Why is Nifty Pharma moving today?
Nifty Pharma moved lower today because declines in several prominent stocks, including Sun Pharmaceutical Industries, Cipla, Dr. Reddy’s Laboratories, and Mankind Pharma, outweighed gains in stocks such as Ipca Laboratories and Torrent Pharmaceuticals.
Which stock contributed the most on the upside today?
Ipca Laboratories was the strongest gainer in Nifty Pharma today, rising 8.67% and standing out as the most powerful positive mover within the sector.
Which stock fell the most today?
JB Chemicals & Pharmaceuticals fell the most in Nifty Pharma today, declining 3.87% and ranking as the worst-performing stock in the tracked sector basket.
How many stocks advanced in Nifty Pharma today?
Ten stocks advanced in Nifty Pharma today, while ten declined. That produced an even market breadth split and an advance-decline ratio of 1.00.
Google AI Overview Style Summary
Nifty Pharma today closed at 26,341.55, down 0.39% after giving up early gains. The index opened above the previous close but weakened through the session and finished near the day’s low. Internal breadth was evenly split with 10 gainers and 10 losers, showing that the decline was driven more by weakness in key stocks than by broad-based selling. Ipca Laboratories was the top gainer, while JB Chemicals & Pharmaceuticals was the top loser. Important heavyweight drags included Sun Pharmaceutical Industries, Cipla, Dr. Reddy’s Laboratories, and Mankind Pharma. Investors may watch whether heavyweight stocks stabilize and whether today’s leading gainers see follow-through in the next session.
Published on 17 August 2026 at 4:05 PM IST
Know more with Univest
Log in to Univest to explore market insights, track stocks, and get 3 free trade ideas on Share Market Today.
Frequently Asked Questions
1. What is the Nifty Pharma index today?
Nifty Pharma closed at 26,341.55 today, down 104 points or 0.39% from the previous close.
2. Why is Nifty Pharma down today?
The index declined because losses in several key pharma stocks, especially Sun Pharmaceutical Industries and other notable names, outweighed gains in a smaller set of advancing stocks.
3. Is Nifty Pharma bullish or bearish today?
For today’s session, the trend was mildly bearish because the index closed below the previous close and finished near the lower end of its intraday range.
4. How many Nifty Pharma stocks advanced today?
Ten stocks advanced in the sector today.
5. How many Nifty Pharma stocks declined today?
Ten stocks declined in the sector today.
6. What is the advance-decline ratio of Nifty Pharma today?
The advance-decline ratio is 1.00, showing an equal number of gainers and losers.
7. Which stock gained the most in Nifty Pharma today?
Ipca Laboratories gained the most today, rising 8.67%.
8. Which stock fell the most in Nifty Pharma today?
JB Chemicals & Pharmaceuticals fell the most today, declining 3.87%.
9. Which heavyweight stocks were weak in Nifty Pharma today?
Sun Pharmaceutical Industries, Cipla, Dr. Reddy’s Laboratories, Mankind Pharma, and Abbott India were among the heavyweight names that closed lower.
10. Which heavyweight stocks supported Nifty Pharma today?
Torrent Pharmaceuticals, Lupin, Aurobindo Pharma, and Divi’s Laboratories were among the tracked heavyweight names that ended in positive territory.
11. Did Nifty Pharma hold its opening gains today?
No. The index opened above the previous close, touched an early high, and then slipped lower through the session.
12. What should traders watch in Nifty Pharma next?
Traders should watch whether heavyweight stocks stabilize and whether today’s strongest gainers continue to see follow-through buying in the next session.
Disclaimer
Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.
